When using molecular targeted drugs, downregulation of VEGF, normalisation of the tumour vasculature, pruning of excess vessels and reduction of interstitial fluid pressure and vessel permeability occur in the tumour consecutively [24–29]. Here, VEGFA is linked to neoplasm.